STEM subjects (Science, Technology, Engineering and Mathematics) are widely regarded as having some of the biggest gaps in diversity, particularly when it comes to gender equality.
While research has consistently shown that gender equality greatly benefits business (with one study from Forbes finding that teams with equal numbers of men and women generate on average 41 percent more revenue for their employer), you’d still be hard pressed to find a university classroom in a STEM subject where the amount of female students is higher than, or even equal to, their male counterparts.
Furthermore, the Organization for Economic Co-operation and Development (OECD) states that less than 20 percent of students registered on STEM PhD programs are female.
One woman helping to break down the barriers is Robyn Kiy, a first-year pharmacology PhD student at the University of Liverpool. After completing her undergraduate degree in pharmacology at the university, she decided to undertake a master’s with Liverpool which took her on placement to Cambridge with MedImmune (now a part of Astra Zeneca), before returning north to start her PhD.
Robyn describes how she initially decided on pharmacology:
“I just stumbled across pharmacology when I was desperately looking at UCAS forms! It seemed like the perfect balance of a lot of human biology and bits of chemistry, and you can see how it could be applied in the real world to improve health.”
Due to the coronavirus outbreak, Robyn’s own lab work has had to take a back seat, as universities across the country have closed their doors. Robyn says that it’s “frustrating that it’s been put on hold”, but that she’s able to fill her time with writing reviews and catch up on reading.



Get closer to your dream programme
Your consent preferences have been set.
Time to start exploring.
Your account has been removed.
You can still browse the site or sign up again once you have parental consent.
Get closer to your dream programme